145 related articles for article (PubMed ID: 15877898)
1. Mucosal bacteria in ulcerative colitis.
Macfarlane S; Furrie E; Kennedy A; Cummings JH; Macfarlane GT
Br J Nutr; 2005 Apr; 93 Suppl 1():S67-72. PubMed ID: 15877898
[TBL] [Abstract][Full Text] [Related]
2. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.
Furrie E; Macfarlane S; Kennedy A; Cummings JH; Walsh SV; O'neil DA; Macfarlane GT
Gut; 2005 Feb; 54(2):242-9. PubMed ID: 15647189
[TBL] [Abstract][Full Text] [Related]
3. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis.
Macfarlane S; Furrie E; Cummings JH; Macfarlane GT
Clin Infect Dis; 2004 Jun; 38(12):1690-9. PubMed ID: 15227614
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.
Mylonaki M; Rayment NB; Rampton DS; Hudspith BN; Brostoff J
Inflamm Bowel Dis; 2005 May; 11(5):481-7. PubMed ID: 15867588
[TBL] [Abstract][Full Text] [Related]
5. Bacterial milieu and mucosal bacteria in ulcerative colitis.
Macfarlane GT; Furrie E; Macfarlane S
Novartis Found Symp; 2004; 263():57-64; discussion 64-70, 211-8. PubMed ID: 15669634
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers.
Duranti S; Gaiani F; Mancabelli L; Milani C; Grandi A; Bolchi A; Santoni A; Lugli GA; Ferrario C; Mangifesta M; Viappiani A; Bertoni S; Vivo V; Serafini F; Barbaro MR; Fugazza A; Barbara G; Gioiosa L; Palanza P; Cantoni AM; de'Angelis GL; Barocelli E; de'Angelis N; van Sinderen D; Ventura M; Turroni F
FEMS Microbiol Ecol; 2016 Dec; 92(12):. PubMed ID: 27604252
[TBL] [Abstract][Full Text] [Related]
7. Mucosal adhesion and anti-inflammatory effects of
Pagnini C; Corleto VD; Martorelli M; Lanini C; D'Ambra G; Di Giulio E; Delle Fave G
World J Gastroenterol; 2018 Nov; 24(41):4652-4662. PubMed ID: 30416313
[TBL] [Abstract][Full Text] [Related]
8. Inulin and oligofructose: impact on intestinal diseases and disorders.
Guarner F
Br J Nutr; 2005 Apr; 93 Suppl 1():S61-5. PubMed ID: 15877897
[TBL] [Abstract][Full Text] [Related]
9. Intestinal bacteria and ulcerative colitis.
Cummings JH; Macfarlane GT; Macfarlane S
Curr Issues Intest Microbiol; 2003 Mar; 4(1):9-20. PubMed ID: 12691258
[TBL] [Abstract][Full Text] [Related]
10. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.
Furrie E; Macfarlane S; Cummings JH; Macfarlane GT
Gut; 2004 Jan; 53(1):91-8. PubMed ID: 14684582
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis.
Fujimori S; Gudis K; Mitsui K; Seo T; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
Nutrition; 2009 May; 25(5):520-5. PubMed ID: 19201576
[TBL] [Abstract][Full Text] [Related]
12. The rectal mucosal but not fecal microbiota detects subclinical ulcerative colitis.
Lin YF; Sung CM; Ke HM; Kuo CJ; Liu WA; Tsai WS; Lin CY; Cheng HT; Lu MJ; Tsai IJ; Hsieh SY
Gut Microbes; 2021; 13(1):1-10. PubMed ID: 33525983
[TBL] [Abstract][Full Text] [Related]
13.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
14. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
15. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers.
Lavelle A; Lennon G; O'Sullivan O; Docherty N; Balfe A; Maguire A; Mulcahy HE; Doherty G; O'Donoghue D; Hyland J; Ross RP; Coffey JC; Sheahan K; Cotter PD; Shanahan F; Winter DC; O'Connell PR
Gut; 2015 Oct; 64(10):1553-61. PubMed ID: 25596182
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Analyses of Gut-Associated Bacterial Microbiota in Ulcerative Colitis Patients.
Al-Bayati L; Nayeri Fasaei B; Merat S; Bahonar A
Arch Iran Med; 2018 Dec; 21(12):578-584. PubMed ID: 30634855
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration.
Fite A; Macfarlane S; Furrie E; Bahrami B; Cummings JH; Steinke DT; Macfarlane GT
J Clin Microbiol; 2013 Mar; 51(3):849-56. PubMed ID: 23269735
[TBL] [Abstract][Full Text] [Related]
18. Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.
Toumi R; Abdelouhab K; Rafa H; Soufli I; Raissi-Kerboua D; Djeraba Z; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):403-9. PubMed ID: 23638770
[TBL] [Abstract][Full Text] [Related]
19. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.
Bartosch S; Woodmansey EJ; Paterson JC; McMurdo ME; Macfarlane GT
Clin Infect Dis; 2005 Jan; 40(1):28-37. PubMed ID: 15614689
[TBL] [Abstract][Full Text] [Related]
20. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
Lennon G; Balfe Á; Bambury N; Lavelle A; Maguire A; Docherty NG; Coffey JC; Winter DC; Sheahan K; O'Connell PR
Colorectal Dis; 2014 May; 16(5):O161-9. PubMed ID: 24345279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
